Ahead of the August 14 vote, RE/MAX supplements its proxy with the post-merger board slate, details on two shareholder lawsuits, and previously omitted financial analysis inputs
RMAX sits 78% above its 52-week low of $5.46.
Summary
RE/MAX filed supplemental proxy materials disclosing the post-merger board of directors, two shareholder lawsuits challenging the merger disclosures, and detailed financial analysis inputs from J.P. Morgan. The shareholder vote remains scheduled for August 14.
Key Events · M&A and Partnerships · RMAX
-
Post-Merger Board Revealed
The combined company, Real REMAX Group, will have a 10-member board: Tamir Poleg as Chair, Erik Carlson (RE/MAX CEO), and eight independent directors. Sharran Srivatsaa will serve as Director Emeritus without voting power.
-
Shareholder Lawsuits Disclosed
Two complaints—Burke and Jones—were filed in New York Supreme Court on July 22–23, 2026, alleging the proxy omitted material information about the merger background, financial projections, and J.P. Morgan's analyses. While the companies deny the allegations, they are supplementing disclosures to avoid delays.
-
Supplemental Financial Disclosures
J.P. Morgan's analysis now includes specific FV/2026E EBITDA multiples (e.g., Real 20.5x, REMAX 6.1x), terminal multiple ranges (8.0x–9.4x for REMAX, 16.3x–20.7x for Real), and discount rates of 11.0%–12.0%. The intrinsic value creation analysis shows approximately 24.3% implied incremental value for REMAX holders.
-
Vote Timeline Unchanged
The special meetings of Real securityholders and REMAX stockholders remain scheduled for August 14, 2026. The boards continue to unanimously recommend approval of the merger.
Analysis · RMAX · Real Estate & Construction
This proxy supplement lays out the full board for the combined company, reveals two shareholder lawsuits alleging inadequate disclosures, and provides granular financial analysis inputs that had been omitted. The litigation and the detailed financial data—including specific multiples, terminal growth rates, and discount rate ranges—are material new facts that could sway how shareholders vote on the merger. The filing also confirms that the August 14 special meeting date remains unchanged, keeping the timeline tight.
At the time of this filing, RMAX was trading at $9.70 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $328.6M. The 52-week trading range was $5.46 to $11.81. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.